Michael Eder

1.6k total citations · 1 hit paper
59 papers, 1.0k citations indexed

About

Michael Eder is a scholar working on Oncology, Transplantation and Molecular Biology. According to data from OpenAlex, Michael Eder has authored 59 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 12 papers in Transplantation and 11 papers in Molecular Biology. Recurrent topics in Michael Eder's work include Renal Transplantation Outcomes and Treatments (11 papers), Polyomavirus and related diseases (11 papers) and Renal Diseases and Glomerulopathies (6 papers). Michael Eder is often cited by papers focused on Renal Transplantation Outcomes and Treatments (11 papers), Polyomavirus and related diseases (11 papers) and Renal Diseases and Glomerulopathies (6 papers). Michael Eder collaborates with scholars based in Austria, Germany and Switzerland. Michael Eder's co-authors include Uwe Schlattner, Theo Wallimann, Karin Fritz‐Wolf, Thorsten Hornemann, Max Dolder, Wolfgang Kabsch, Eddie O’Gorman, Dieter Brdiczka, E. Ziegler and Martin Stolz and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Biochemistry.

In The Last Decade

Michael Eder

55 papers receiving 997 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Second International Consensus Guidelines on the Management of BK Polyomavirus in Kidney Transplantation

2024 49 citations Camille N. Kotton, Nassim Kamar et al. Transplantation profile →

Peers

Countries citing papers authored by Michael Eder

Since Specialization

Citations

This map shows the geographic impact of Michael Eder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Eder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Eder more than expected).

Fields of papers citing papers by Michael Eder

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Eder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Eder. The network helps show where Michael Eder may publish in the future.

Co-authorship network of co-authors of Michael Eder

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Eder. A scholar is included among the top collaborators of Michael Eder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Eder. Michael Eder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	T1 Relaxation Time for the Prediction of Renal Transplant Dysfunction 2025 ·Transplant International ·(unknown), Farsad Eskandary, Dietrich Beitzke, Marcos Wolf, Nicolas Kozakowski, Georg A. Böhmig, (unknown), Michael Eder	0
2	A systematic literature review and meta-analysis evaluated modifiable risk factors for the development of BK polyoma virus–associated complications 2025 ·Kidney International ·Michael Eder, Alexander Kainz, (unknown), Christof Aigner, Dragan Copic, Camille N. Kotton, Nassim Kamar, David Wojciechowski, Hans H. Hirsch, Rainer Oberbauer	1
3	The Second International Consensus Guidelines on the Management of BK Polyomavirus in Kidney Transplantation breakdown → 2024 ·Transplantation ·Camille N. Kotton, Nassim Kamar, David Wojciechowski, Michael Eder, Helmut Hopfer, Parmjeet Randhawa, Martina Sester, Patrizia Comoli, Hélio Tedesco‐Silva, Greg Knoll, Daniel C. Brennan, Jennifer Trofe‐Clark, Lars Pape, David A. Axelrod, Bryce Kiberd, Germaine Wong, Hans H. Hirsch, (unknown)	49
4	Shedding Light on Viral Shedding: Novel Insights into Nuclear Assembly, Cytoplasmic Transformation and Extracellular Vesicle Release of the BK Virus 2024 ·International Journal of Molecular Sciences ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Wolfgang Winnicki, Michael Eder, Alice Schmidt, Farsad Eskandary, Ludwig Wagner	2
5	Peritubular and Tubulointerstitial Inflammation as Predictors of Impaired Viral Clearance in Polyomavirus Nephropathy 2024 ·Journal of Clinical Medicine ·(unknown), Michael Eder, (unknown), Nicolas Kozakowski, Johannes Kläger, Gregor Bond, Željko Kikić	0
6	Effect of increasing age and ureteral stent implantation on urinary tract infections after kidney transplantation – update of recent literature 2024 ·Current Opinion in Urology ·(unknown), Michael Eder	1
7	Lessons for the Clinical Nephrologist: Nephrotic syndrome associated with refractory Giardia duodenalis infection in a patient with acquired B cell depletion 2023 ·Journal of Nephrology ·Michael Eder, (unknown), Georg A. Böhmig, Barbara Kornek, Lisa Göschl, Gregor Bond, Matthias G. Vossen, Winfried F. Pickl, (unknown), Irene Görzer, Nicolas Kozakowski, Hermann Laferl, Stefan Winkler	1
8	Diagnostic value of donor‐derived cell‐free DNA to predict antibody‐mediated rejection in donor‐specific antibody‐positive renal allograft recipients 2021 ·Transplant International ·Katharina A. Mayer, Konstantin Doberer, (unknown), (unknown), Susanne Haindl, (unknown), Roman Reindl‐Schwaighofer, Michael Eder, Farsad Eskandary, Sı́lvia Casas, Markus Wahrmann, Heinz Regele, Georg A. Böhmig	30
9	COVID-19: IgG seroconversion under intensive glucocorticoid treatment in a high-risk patient with minimal change disease 2020 ·Wiener klinische Wochenschrift ·Michael Eder, Robert Straßl, Johannes Kläger, Christof Aigner, Florian Thalhammer, Željko Kikić	1
10	Next generation sequencing based assessment of the alloreactive T cell receptor repertoire in kidney transplant patients during rejection: a prospective cohort study 2019 ·BMC Nephrology ·Constantin Aschauer, Kíra Jelencsics, Karin Hu, Andreas Heinzel, (unknown), (unknown), (unknown), Stephan Winkler, (unknown), Guido A. Gualdoni, Michael Eder, Alexander Kainz, Heinz Regele, Roman Reindl‐Schwaighofer, Rainer Oberbauer	15
11	Protocol TOP-Study (tacrolimus organ perfusion): a prospective randomized multicenter trial to reduce ischemia reperfusion injury in transplantation of marginal liver grafts with an ex vivotacrolimus perfusion 2013 ·PubMed ·Sebastian Pratschke, Michael Eder, Michael Heise, Silvio Nadalin, Andreas Pascher, Peter Schemmer, Marcus N. Scherer, Frank Ulrich, Heiner Wolters, Karl‐Walter Jauch, (unknown), Martin K. Angele	10
12	Der Einfluss von Bekleidung auf die sphygmomanometrische und oszillometrische Blutdruckmessung bei Hypertonikern 2008 ·DMW - Deutsche Medizinische Wochenschrift ·Michael Eder, H. Holzgreve, Max Emanuel Liebl, Johannes R. Bogner	5
13	Pflanzliche Begleitstoffe — wertvolle Hilfsstoffe oder überflüssiger Ballast? 2000 ·Pharmazie in unserer Zeit ·Michael Eder, W. Mehnert	6
14	Comparison of MPA trough levels in patients with severe diabetes mellitus and from non-diabetics after transplantation 1999 ·Transplantation Proceedings ·B Zanker, (unknown), Michael Eder, (unknown), W. Land	7
15	Crystal structure of brain‐type creatine kinase at 1.41 Å resolution 1999 ·Protein Science ·Michael Eder, Uwe Schlattner, Theo Wallimann, Andreas Becker, Wolfgang Kabsch, Karin Fritz‐Wolf	85
16	Some new aspects of creatine kinase (CK): compartmentation, structure, function and regulation for cellular and mitochondrial bioenergetics and physiology 1998 ·BioFactors ·Theo Wallimann, Max Dolder, Uwe Schlattner, Michael Eder, Thorsten Hornemann, Eddie O’Gorman, (unknown), Dieter Brdiczka	187
17	Creatine kinase: An enzyme with a central role in cellular energy metabolism 1998 ·Magnetic Resonance Materials in Physics Biology and Medicine ·Theo Wallimann, Max Dolder, Uwe Schlattner, Michael Eder, Thorsten Hornemann, (unknown), Martin Stolz	64
18	Characterization of Human and Pig Kidney Long‐Chain‐Acyl‐CoA Dehydrogenases and their Role in β‐Oxidation 1997 ·European Journal of Biochemistry ·Michael Eder, (unknown), Dong Yü, (unknown), (unknown), Jung‐Ja P. Kim, Arnold W. Strauss, Sandro Ghisla	15
19	Histopathologie von Netzhaut, Fasciculus opticus und Corpus geniculatum laterale bei länger bestehender, symmetrisch bilateraler ischämischer Schnabelscher kavernöser Optikusatrophie 1990 ·Klinische Monatsblätter für Augenheilkunde ·F. H. Stefani, (unknown), P. Mehraein, Michael Eder	6
20	[Morphological and experimental studies on fibrosis formation in carcinoid]. 1959 ·PubMed ·Michael Eder, (unknown)	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact